Ibex Investors LLC - ZIOPHARM ONCOLOGY INC ownership

ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 150 filers reported holding ZIOPHARM ONCOLOGY INC in Q1 2020. The put-call ratio across all filers is 0.94 and the average weighting 0.1%.

Quarter-by-quarter ownership
Ibex Investors LLC ownership history of ZIOPHARM ONCOLOGY INC
ValueSharesWeighting
Q4 2019$504,000
+172.4%
107,067
+147.8%
0.00%
-75.0%
Q3 2019$185,000
-75.9%
43,203
-67.2%
0.01%
-81.0%
Q2 2019$768,000
+7.7%
131,816
-28.9%
0.06%
-1.6%
Q1 2019$713,000
-5.6%
185,287
-54.1%
0.06%
-48.0%
Q4 2018$755,000403,6500.12%
Other shareholders
ZIOPHARM ONCOLOGY INC shareholders Q1 2020
NameSharesValueWeighting ↓
DISCOVERY CAPITAL MANAGEMENT, LLC / CT 15,461,829$2,037,8690.36%
MSD Partners, L.P. 15,151,516$1,996,9700.16%
MSD Partners, L.P. 7,575,758$998,4850.08%
MAGNOLIA CAPITAL ADVISORS LLC 865,938$65,5520.03%
Allred Capital Management, LLC 253,000$33,3450.02%
CHIRON CAPITAL MANAGEMENT, LLC 77,023$10,1520.01%
Boxer Capital, LLC 1,100,000$144,9800.01%
GSA CAPITAL PARTNERS LLP 569,566$750.01%
Sugarloaf Wealth Management, LLC 75,500$9,9510.00%
Owen LaRue, LLC 11,825$1,5590.00%
View complete list of ZIOPHARM ONCOLOGY INC shareholders